OBJECTIVE: Our goal was to determine the validity of authors' inferences ab
out the value of the cervicovaginal fetal fibronectin test in the predictio
n of preterm birth and the utility of uterine artery Doppler waveform analy
sis in the prediction of preeclampsia.
STUDY DESIGN: We evaluated all 35 diagnostic test studies (14 on fetal fibr
onectin and 21 on uterine artery Doppler) included in 2 meta-analyses. The
information on authors' conclusions regarding the value of a positive or ne
gative test result was independently abstracted from each article by 2 revi
ewers, and it was classified as definitely useful, moderately useful, sligh
tly useful, or not at all useful, For the "gold" standard, likelihood ratio
s of >10 and <0.1 were regarded as definitely useful, 5 to 10 and 0.1 to 0.
2 were regarded as moderately useful, 2 to 5 and 0.2 to 0.5 were regarded a
s slightly useful, and 1 to 2 and 0.5 to 1 were regarded as not at all usef
ul. The agreement between the authors and the reference standard was comput
ed by simple percentage agreement and weighted kappa statistic.
RESULTS: Among articles assessing the diagnostic value of fetal fibronectin
the simple agreement between the authors and the "gold" standard was 26% (
7/26) with a kappa of 0.05 (P = .83), and authors overestimated the value o
f the test result in 66% (17/26) of instances. Similarly, among articles as
sessing uterine artery Doppler the simple agreement between the authors and
the "gold" standard was 31% (13/42) with a ic of 0.28 (P = .31), and autho
rs overestimated the value of the test result in 48% (20/42) of instances.
CONCLUSION: Authors claimed more positive conclusions than could be support
ed by their data. When studies are reported in a misleading manner, the cha
nce of misinterpretation on the part of the clinical reader is increased. T
he use of explicit criteria that are based on likelihood ratios may reduce
the risk of erroneous inferences.